I’m having similar issues with 4DX, who has a doctor as a CEO and they also seem to over hype things and fail to deliver despite having a revolutionary product at cheaper prices. Sounds familiar?
Xperience is fresh to market but won’t be surprised a year on minimal sales traction has been gained. Then like 4DX you start to question the product as I am now on NXS pre existing suite which hasn’t delivered.
Ann: Update on expected revenue for H1, page-46
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.5¢ |
Change
0.005(1.32%) |
Mkt cap ! $110.8M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 38.5¢ | 38.5¢ | $2.543K | 6.604K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 16539 | 38.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.5¢ | 3063 | 1 |
View Market Depth
| Last trade - 11.10am 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
38.0¢ |
Change
0.005 ( 1.33 %) |
||||
| Open | High | Low | Volume | ||
| 38.5¢ | 39.0¢ | 38.0¢ | 2072 | ||
| Last updated 11.53am 15/05/2024 ? | |||||
| NXS (ASX) Chart |